APACE SYSCORP PRIVATE LIMITED
Founded in 2017
About APACE SYSCORP PRIVATE LIMITED
APACE SYSCORP PRIVATE LIMITED is revolutionizing cancer treatment in India. With cancer on the verge of becoming an epidemic, the company aims to provide affordable diagnostic options for patients. They have developed a proprietary method called the tumor organoid (tumoroid) culture system, which replicates the complexity of patients' tumors. This system allows for personalized testing of drug combinations specific to each patient, addressing therapy response and resistance. By offering a breakthrough model that reflects human cancer biology, APACE SYSCORP is ushering in an era of truly personalized medicine. Their goal is to make tumoroid-ba (Show more)
Founders of APACE SYSCORP PRIVATE LIMITED
Public Links of APACE SYSCORP PRIVATE LIMITED
Frequently Asked Questions (FAQ)
When was APACE SYSCORP PRIVATE LIMITED founded?
APACE SYSCORP PRIVATE LIMITED was founded in the year 2017.
Who are the founders of APACE SYSCORP PRIVATE LIMITED?
APACE SYSCORP PRIVATE LIMITED is founded by Dibyendu Das
Who are APACE SYSCORP PRIVATE LIMITED's competitors?
Possible competitors of APACE SYSCORP PRIVATE LIMITED may include Beyondtech It Solutions, Cardis Labs, Eon Therapy and 7 others.
Get Access to Complete Information
Signup NowDetails insufficient or not accurate? Suggest edits
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
